Publication|Videos|August 8, 2024
Reducing Patient Dropout Rates and Accelerating Trial Completion
Author(s)PCM Trials
Jon Ernst (Vice President, In-Home Solutions, Decentralized Clinical Trials) discusses today's clinical trial landscape.
Jon Ernst talked with ACT about how PCM Trials are harmonizing various elements in the decentralized clinical trial process.
Learn More About:
- The benefits of home visits in decentralized clinical trials
- What to look for in a home visit vendor for a successful study
- How home visits and community research sites have been misunderstood
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
FDA Approves Komzifti for NPM1-Mutated AML Based on Positive Phase I/II KOMET-001 Trial Data
2
Proactive Planning is Key to Mitigating Study Rescue
3
Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV
4
ACT Brief: Site Satisfaction, eSource Data Transfers, and Gilead HIV Trial Results
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
